New Key Statistics Module, Z-Score and F-Score
SZSE:300702 Key Ratios
Market Cap ¥ M | 6,051.32 |
Enterprise Value ¥ M | 7,097.62 |
P/E(ttm) | 144.92 |
PE Ratio without NRI | 95.03 |
Forward PE Ratio | 27.60 |
Price/Book | 1.71 |
Price/Sales | 2.37 |
Price/Free Cash Flow | 25.98 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.27 |
Revenue (TTM) ¥ M | 2,594.00 |
EPS (TTM) ¥ | 0.12 |
Beneish M-Score | -2.81 |
10-y EBITDA Growth Rate % | 16.30 |
5-y EBITDA Growth Rate % | -10.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 51.68 |
EV-to-EBITDA | 51.68 |
PEG | -- |
Shares Outstanding M | 347.98 |
Net Margin (%) | 1.68 |
Operating Margin % | 7.68 |
Pre-tax Margin (%) | 3.15 |
Quick Ratio | 0.43 |
Current Ratio | 1.15 |
ROA % (ttm) | 0.69 |
ROE % (ttm) | 1.24 |
ROIC % (ttm) | 2.15 |
Dividend Yield % | 0.30 |
Altman Z-Score | 2.11 |
SZSE:300702 Number of Guru Trades
SZSE:300702 Volume of Guru Trades
Gurus Latest Trades with SZSE:300702
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300702 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Tianyu Pharmaceutical Co Ltd Insider Transactions
No Available Data